Subscribe to
this category


A total of 46 posts are filed under Finance
CureGenetics raises $17 million
Rare Daily Staff China-based CureGenetics said it closed a $17 million series A financing, which will be used to optimize its gene editing… Continue Reading
Viagra Inventor Raises $10M to Accelerate Rare Disease Drug Discovery with AI
Rare Daily Staff Healx, a U.K.-based technology company using artificial intelligence to accelerate the discovery of treatments for rare… Continue Reading
Rare Metabolic Drug Developer Closes Seed Funding, Names CEO
Rare Daily Staff Azafaros, a Netherlands-based biotech developing therapies for rare metabolic disorders, said it completed a seed financing… Continue Reading
Rubius Completes Upsized $241.1 Million IPO
Rare Daily Staff Rubius Therapeutics, which is developing therapies for rare and other diseases, completed a $241.1 million IPO selling… Continue Reading
Modus Raises $15.7 Million to Advance Sickle Cell Disease Therapy
Rare Daily Staff Modus Therapeutics said it has raised $15.7 million (SEK 140 million) to advance development of its sickle cell disease… Continue Reading
Dynacure Raises $55 Million to Develop Antisense Therapy for Rare Muscular Disorders
Rare Daily Staff Dynacure said it raised more than $55 million (€47 million) to advance its lead antisense program into clinical… Continue Reading
CVC Capital Partners Buys Controlling Stake in Recordati for $3.5 Billion
Rare Daily Staff A consortium of funds led by CVC Capital Partners has agreed to buy a majority interest in drugmaker Recordati for $3.5… Continue Reading
1 2 3 7

Follow us on Twitter